BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Apthera, Inc. (Acquired by RXi Pharmaceuticals) 

Press releases archived for reference only.
14861 N. Scottsdale Road, Suite 201
Scottsdale  Arizona  85254  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





 Company News
RXi Pharmaceuticals (RXII) Completes Apthera, Inc. Acquisition 4/14/2011 1:36:03 PM    More...
Apthera, Inc. and RXi Pharmaceuticals (RXII) Announce Definitive Merger Agreement Valued at $7.2 Million, Names New CEO 3/31/2011 6:53:51 AM    More...
Dr. Mark W. Schwartz Joins Apthera, Inc. as President & CEO 1/8/2010 7:04:05 AM    More...
Investment Banking Executive Ira Z. Leiderman and Dr. Mary Ann Gray Join the Board of Directors at Apthera, Inc. 10/9/2009 8:22:02 AM    More...
Apthera, Inc. Receives Special Protocol Assessment (SPA) From FDA for Pivotal Phase III Trial of NeuVax in Early-Stage Breast Cancer 6/25/2009 10:10:34 AM    More...
Apthera, Inc. Announces Product License Agreement With Kwang Dong Pharmaceutical 6/4/2009 11:28:45 AM    More...
Apthera, Inc. Announces Phase III and Commercial Drug Formulation for NeuVax(TM) 12/9/2008 8:33:18 AM    More...
Apthera, Inc. Announces Optimal Dose And Schedule Of Neuvax For Phase III Clinical Trial In Breast Cancer 10/1/2008 10:01:45 AM    More...
Apthera, Inc. and TGen Drug Development Services (TD2) Sign Master Services Agreement 8/5/2008 9:09:59 AM    More...
Apthera, Inc.'s NeuVax™ Produces Delays in Recurrence in High-Risk HER2-Positive Prostate Cancer Patients 6/2/2008 11:35:25 AM    More...
12

//-->